The third -- and what some retailers say could be the biggest -- entry to the booming prescription to over-the-counter H2 antagonist segment is expected to hit supermarket shelves early this year. Zantac 75, from Warner Wellcome Consumer Healthcare, London, received OTC clearance from the Food and Drug Administration late last month. The company, which said the drug will be available early this year, has yet to announce pricing or an exact ship date. Indicated for the relief of heartburn, ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.